Julie Wang1, Michael C Young, Anna Nowak-Węgrzyn. 1. Division of Pediatric Allergy and Immunology, Jaffe Food Allergy Institute, Kravis Children's Hospital, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Abstract
BACKGROUND: Studies show that anaphylaxis is under-recognized and epinephrine (adrenaline) is under-used by medical personnel as well as patients and their families. This study assesses the knowledge of food-induced anaphylaxis diagnosis and management across different populations of providers and caregivers and other interested respondents. METHODS: An online survey embedded in a case discussion of food-induced anaphylaxis was distributed by Medscape to registered members. RESULTS: A total of 7822 responders who started the activity chose to answer at least some of the questions presented (response rate 39.5%). Over 80% of responders in all groups correctly identified the case of anaphylaxis with prominent skin and respiratory symptoms; however, only 55% correctly recognized the case without skin symptoms as anaphylaxis. Only 23% of responders correctly selected risk factors for anaphylaxis, with physicians significantly more likely to choose the correct answers as compared to allied health, other health professionals, and medical students (p < 0.001). Ninety-five percent selected epinephrine (adrenaline) as the most appropriate treatment for anaphylaxis, and 81% correctly indicated that there are no absolute contraindications for epinephrine (adrenaline) in the setting of anaphylaxis. When presented a case of a child with no documented history of allergies who has symptoms of anaphylaxis, more physicians than any other group chose to administer stock epinephrine (adrenaline) (73% vs. 60%, p < 0.001). CONCLUSION: Specific knowledge deficits for food-induced anaphylaxis persist across all groups. Further educational efforts should be aimed not only at the medical community but also for the entire caregiver community and general public, to optimize care for food allergic individuals.
BACKGROUND: Studies show that anaphylaxis is under-recognized and epinephrine (adrenaline) is under-used by medical personnel as well as patients and their families. This study assesses the knowledge of food-induced anaphylaxis diagnosis and management across different populations of providers and caregivers and other interested respondents. METHODS: An online survey embedded in a case discussion of food-induced anaphylaxis was distributed by Medscape to registered members. RESULTS: A total of 7822 responders who started the activity chose to answer at least some of the questions presented (response rate 39.5%). Over 80% of responders in all groups correctly identified the case of anaphylaxis with prominent skin and respiratory symptoms; however, only 55% correctly recognized the case without skin symptoms as anaphylaxis. Only 23% of responders correctly selected risk factors for anaphylaxis, with physicians significantly more likely to choose the correct answers as compared to allied health, other health professionals, and medical students (p < 0.001). Ninety-five percent selected epinephrine (adrenaline) as the most appropriate treatment for anaphylaxis, and 81% correctly indicated that there are no absolute contraindications for epinephrine (adrenaline) in the setting of anaphylaxis. When presented a case of a child with no documented history of allergies who has symptoms of anaphylaxis, more physicians than any other group chose to administer stock epinephrine (adrenaline) (73% vs. 60%, p < 0.001). CONCLUSION: Specific knowledge deficits for food-induced anaphylaxis persist across all groups. Further educational efforts should be aimed not only at the medical community but also for the entire caregiver community and general public, to optimize care for food allergic individuals.
Authors: Ryan C Jacobsen; Serkan Toy; Aaron J Bonham; J A Salomone; Jacob Ruthstrom; Matthew Gratton Journal: Prehosp Emerg Care Date: 2012-06-19 Impact factor: 3.077
Authors: Nicole J Goossens; Bertine M J Flokstra-de Blok; Gerbrich N van der Meulen; Erna Botjes; Hans G M Burgerhof; Ruchi S Gupta; Elizabeth E Springston; Bridget Smith; Eric J Duiverman; Anthony E J Dubois Journal: Pediatr Allergy Immunol Date: 2013-06-25 Impact factor: 6.377
Authors: Wyatt W Decker; Ronna L Campbell; Veena Manivannan; Anuradha Luke; Jennifer L St Sauver; Amy Weaver; M Fernanda Bellolio; Eric J Bergstralh; Latha G Stead; James T C Li Journal: J Allergy Clin Immunol Date: 2008-11-06 Impact factor: 10.793
Authors: Susan L Prescott; Ruby Pawankar; Katrina J Allen; Dianne E Campbell; John Kh Sinn; Alessandro Fiocchi; Motohiro Ebisawa; Hugh A Sampson; Kirsten Beyer; Bee-Wah Lee Journal: World Allergy Organ J Date: 2013-12-04 Impact factor: 4.084
Authors: Stefanie Aurich; Sabine Dölle-Bierke; Wojciech Francuzik; Maria Beatrice Bilo; George Christoff; Montserrat Fernandez-Rivas; Thomas Hawranek; Claudia Pföhler; Iwona Poziomkowska-Gȩsicka; Jean-Marie Renaudin; Eva Oppel; Kathrin Scherer; Regina Treudler; Margitta Worm Journal: Front Immunol Date: 2019-04-24 Impact factor: 7.561
Authors: F Estelle R Simons; Motohiro Ebisawa; Mario Sanchez-Borges; Bernard Y Thong; Margitta Worm; Luciana Kase Tanno; Richard F Lockey; Yehia M El-Gamal; Simon Ga Brown; Hae-Sim Park; Aziz Sheikh Journal: World Allergy Organ J Date: 2015-10-28 Impact factor: 4.084
Authors: Daniel Munblit; Marina Treneva; Ilya Korsunskiy; Alan Asmanov; Alexander Pampura; John O Warner Journal: BMJ Open Date: 2017-07-20 Impact factor: 2.692
Authors: Joaquin A Pimentel-Hayashi; Elsy M Navarrete-Rodriguez; Oscar I Moreno-Laflor; Blanca E Del Rio-Navarro Journal: Asia Pac Allergy Date: 2020-10-22